CMON(01792.HK)盈喜:預計年度錄得公司權益持有人應占溢利
格隆匯2月17日丨CMON(01792.HK)發佈公吿,相較集團上年度的虧損約490萬美元,集團預期將於截至2021年12月31日止年度錄得公司權益持有人應占溢利。
公吿稱,截至2020年12月31日止年度的盈利能力受挫,主要是由於受COVID-19大流行影響,中國於2020年第一季度處於封鎖狀態,而由於集團的合約製造商大多位於中國,因此集團無法向客户製作或付運遊戲。2020年第三及第四季度以及2021年全年的銷售已恢復到COVID-19爆發前的水平,而集團的銷售,尤其是對批發商的銷售,已於截至2021年12月31日止年度大幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.